Synapse - Breast Medicine Service

Results (4181)

Molecular subtyping of male breast cancer by the International Male Breast Cancer Program (IMBC): EORTC 10085/TBCRC 0-29/BIG 2-07/NABCG/BOOG 2009-04

Meeting Abstract

Martens, J. W. M.; Sieuwerts, A.; Ponchet, C.; Smid, M.; de Weerd, V.; Slaets, L.; Piper, T.; van Deurzen, C. H. M.; Schroder, C. P.; Stangle, C.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials

Meeting Abstract

Gray, R.; Bradley, R.; Braybrooke, J.; Davies, C.; Pan, H.; Peto, R.; Bliss, J.; Cameron, D.; Mackey, J.; Del Mastro, L.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)

Meeting Abstract

Gucalp, A.; Edelweiss, M.; Patil, S.; Gounder, M. M.; Feigin, K. N.; Corben, A.; Arumov, A.; Traina, T. A.
Cancer Research (2018)

Fulltext@MSK | Save

Health-related quality of life during a phase 2 study of talazoparib in patients with advanced breast cancer and germline BRCA1/2 mutations (ABRAZO)

Meeting Abstract

Hurvitz, S. A.; Turner, N. C.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; Balmaña, J.; Fasching, P. A.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial

Meeting Abstract

Im, S. A.; Xu, B.; Li, W.; Robson, M.; Ouyang, Q.; Yeh, D. C.; Iwata, H.; Park, Y. H.; Sohn, J. H.; Tseng, L. M.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Molecular determinants of post-mastectomy breast cancer recurrence

Meeting Abstract

Keene, K. S.; King, T.; Hwang, E. S.; Peng, B.; McGuire, K.; Tapia, C.; Zhang, H.; Bae, S.; Nakhlis, F.; Klauber-Demore, N.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

Meeting Abstract

Domchek, S. M.; Robson, M.; Im, S. A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Conte, P.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Men with advanced breast cancer (BC): Initial phase (Ph) 2 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor

Meeting Abstract

Elias, A.; Gucalp, A.; Bardia, A.; Resaul, A.; Eisner, J.; Baskin-Bey, E.; Traina, T. A.
Cancer Research (2018)

Fulltext@MSK | Save

Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic and functional analysis

Meeting Abstract

Geyer, F. C.; Li, A.; Papanastasiou, A. D.; Smith, A.; Selenica, P.; Burke, K. A.; Edelweiss, M.; Wen, H. C.; Piscuoglio, S.; Schultheis, A. M.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Improvement in sexual function over time in premenopausal women with breast cancer

Meeting Abstract

Goldfarb, S. B.; Kamer, S.; Baser, R.; Quistorff, J.; Gemignani, M. L.; Dickler, M.
Cancer Research (2018)

Fulltext@MSK | Save